NEW YORK, Sept. 7 (GenomeWeb News) - A jury has found that Stratagene has willfully infringed two nucleic acid testing patents held by Third Wave Technologies, and has awarded Third Wave $5.3 million in damages, Third Wave said yesterday.

 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.